Podcasts about Bain Capital

We have Mike Monaghan on the show today and covering the “Birth of an ETF.” He’s going to talk about the Founders ETF and its new launch. We’re also going to talk a little bit about what it takes to get an ETF up and running. From a compliance perspective, remember, there’s no guarantee of future performance. https://youtu.be/o-m3PYHKXqk?si=qBaHkJpUt7xgdpjG Transcript of “The Birth of an ETF” 00:00 The Founders ETF Frazer Rice (00:00.986)Welcome back, Mike. Michael Monaghan (00:02.616)Frazer, it’s great to be back. Frazer Rice (00:04.4)You are at an interesting point in time right now. You’re about to start up Founders ETF and I think you’re about to get trading authorization to get going. Maybe tell us a little bit about the process to set up an ETF. Then we’ll dive into the strategy a little bit. Michael (00:21.25)Yeah, absolutely right. We should start trading on the SIBO Thursday, so two days from now. And we’ve launched our first fund, the Founders 100, that owns the 100 best founder-led companies. I’d be happy to go through some of the process that it takes to set up an ETF. Frazer Rice (00:40.014)Love it. ETFs are the main way to go now in terms of getting an inveestment cvhicle up and running. What has your experience been around? The Popularity of the ETF Structure Michael (00:52.014)Yeah, so ETFs have become the primary investment vehicle for a few reasons. Let’s outline those reasons. Then we can go through some of the steps that it takes to set up an ETF. So on the advantage side of an ETF, they’re typically a bit lower cost than traditional mutual fund products. Importantly, they’re tax advantaged. So there’s no gains or losses that occur during the normal ETF growth phase. Everything that happens within the ETF is done with what’s called an authorized participant. So you do exchanges. And so there’s no capital gains that are assigned to the investors. As long as they hold the ETF, a tax trigger only occurs when they actually sell the ETF. Finally, it’s a great way to get exposure to the market. So whether you want to own a broad market index, one of the legacy indexes, or a vehicle like ours. That gives you in one single trade, rather than having to guess who’s going to win. Is Nvidia going to win or Palantir who’s going to win? You can own a hundred of the best winners in the market in one single stock ticker. In our case, FFF. Frazer Rice (02:07.364)So let’s dive into that theme a little bit. As you said, it’s the top hundred founder led companies. First and foremost, public I assume, private, you’re not diving in those waters. Public vs Private Michael (02:20.59)Correct. So these are the hundred best publicly traded founder led stocks. And we generally fish from the 200 largest founder led publicly traded stocks. So a lot of these are names and founders that are very well recognized. Whether it’s Elon at Tesla or a Mark at Metta, Larry at Oracle, Rich Fairbanks at Capital One. These are all very well known founders. They’re great entrepreneurs who are leading highly scalable, very high performing publicly traded stocks. 02:53 Understanding Founder-Led Companies Frazer Rice (02:53.914)So let’s define founder a little bit. Obviously we have sort of the cult of personality around high-end CEOs. It sounds like you’re identifying companies that have been founded. The people who are running them not only founded them, but they scaled them. They have now gotten them to a level of maturity. That’s different from the typical public company that we find in the S &P 500. Definition of Founder Michael (03:19.104)Yeah. So first let’s define a founder. Then let’s talk about why we think the founder led companies outperform a traditional S&P company. We define the founder as being a chief executive leader. It could be chief executive officer, could be chief technology officer. Sometimes that say a scientific or medical company, would be the chief scientific or chief medical officer. And that person conceived and founded the company, took it from zero to one. It’s their imprint that has guided it over its 10 or 20 or 30 year period. That’s taken it from a small private company to a venture backed company to a large publicly traded company. And so the idea being the person that founded it continues to run it to this day. We talk about the fact that we own an Nvidia that Jensen still runs. But we don’t own Intel. We own Meta because Mark still runs it, but we don’t own Google. We own Dell computer because Michael Dell still runs it. But we don’t own Apple. We own Capital One because Rich Fairbank still runs it, but we don’t own American Express. Investment Process Frazer Rice (04:25.86)Got it. So lots of things to get into here. How does it a company get on your radar screen? And then ultimately, how does it get off of it? Michael (04:35.806)Great question. the getting on the screen is fairly mechanical. We look at the 200 largest by market capitalization founder led stocks. So we look at all U.S. listed. So it could be listed on the New York Stock Exchange or NASDAQ, but it has to be U.S. listed. We then look at the 200 largest. And from there, we select the 100 best using a quantitative factor model. So I’m have a Sanford Bernstein background and so do some of the folks here. And so for folks who are familiar with Bernstein’s research, we use a Bernstein factor model to pick the best, the hundred best names out of the 200 largest. That’s how they get on our radar. And to get off is quite simple if they retire. So if a CEO announces he’s retiring, per the prospectus, we have 90 days to sell the stock. once we, so for example, Mr. Buffett recently stepped down from Berkshire Hathaway. And so we sell Berkshire Hathaway on his announcement and no longer own the stock. Frazer Rice (05:38.0)things like corporate mergers or divestitures or maybe even a reclassification of stock where the founder stays on in some capacity but their decision making has been reduced. How do you analyze that? 05:54 The Investment Strategy Behind the ETF Michael (05:54.326)Yeah, so there is some human overlay judgment calls here and the founder has to be an executive officer leading the company. So they can’t just run a division. They can’t just be chairman of the board. They have to be the executive in charge of running the company. Frazer Rice (06:14.0)And if for, I guess one of the exits possibly would be if, and I don’t know if this is even possible, but if NVIDIA were to take over Meta and there isn’t room for Jensen and Mark in the same suite, how do you analyze something like that? Michael (06:34.253)So in the business combinations where you have two founder-led companies or a non-founder-led company swallowed up by a founder-led company, as long as an original founder remains, it remains in the portfolio. So we’ve had some stocks that had, say, three to four co-founders. And as long as one of those co-founder remains, it remains in the portfolio. Voting Shares Frazer Rice (06:58.352)So one of the things that’s a bee in my bonnet is the concept of having shares where, in a sense, they’re super majority or voting components and then shareholders that have less decision making authority to act as a check and balance around the company. Is that something you’re not really that worried about or is it something that may be a factor that’s important later on? Michael (07:24.525)So we actually think that’s one of the opportunities that this exists. Like one of the things that we haven’t talked about yet is why is all this alpha there? Why is this uncaptured alpha there for us to go get? And we think historically in the past, active money managers have sometimes shied away from these founder led companies because to your point, Frazier, oftentimes the founder has managed to have super voting control, 10 to one shares, 101 shares. So they completely control the company. And some of these larger active money management complexes have said, well, we as the shareholder, we need to be able to have a vote and we’re going to underown these stocks. We have the opposite view. We think these founders are special. So we think that by the time a Mark or a Elon has driven their company into the public markets, they’ve showed that they know how to set the vision, ruthlessly execute and generate value for the shareholders. Concerns? And so we’re not concerned by super voting structures. Oftentimes those are the stocks that we want to own because it’s the founder that’s in control and setting the direction of the business and generating high returns for the shareholders. We view it as you either believe in them and you own the stock or you don’t believe in them and sell the stock. We’re not interested in other people’s getting on the board and monkeying with the decisions of the founders. Frazer Rice (08:30.255)Is this it? What is it about the founders, especially for those that go from zero to one, then to scale, and then to shepherding a mature business? What makes them better and what drives the alpha that you’re trying to seek? In terms of putting together a portfolio of these types of companies? 09:01 The Importance of Founders in Business Michael (09:02.891)Yeah, so the great ones tend to be a bit irreverent. They tend to be highly visionary. They tend to be charismatic communicators and relentless in their execution ability. They’ve got a great ability to pivot if a change needs to be made. And rthe moral authority to set a tone to generate very high rates of return. We see it sort of over and over and over in these founder led companies. And if you look at some of the studies that we’ve done. There’s a study that Bain Capital, Bain had done years ago in combination with Harvard Business Review, founder led companies tend to outperform non-founder led companies in say the S &P 500 by 3X. So it’s this personality type of high vision and high execution tends to drive outsize returns. And it’s a bit of a self-selecting process. What makes Founders Unique? If you think about it by the time any of these founders that we own or talk about have got to the public market. They first had to identify an opportunity to go after. They had to develop a great product by listening to their customers. And they’ve shown that they can scale all the way from a series A round, B, C, D, all the way investing and generating high rates of return in the private markets. Transitions of Founders to Executives They get to the public markets, continue to do that. And now you get a little bit of an effect of a echo of that, of now all of sudden you’re in the public markets. If you get enough scale, you have this highly effective business. Now you’re getting relatively cheap capital that you’re feeding into your business through the public markets. And now you continue to grow. Frazer Rice (10:42.096)Just to summarize at least what I’m hearing is that they’ve gotten to the point of becoming public. They’ve been able to say no to losing control in exchange for either putting some liquidity back in their pocket or otherwise moving on. And so they’ve almost ratified their vision and message and they keep going. And by the fact that they’re public, there’s enough liquidity for everyone else out there in terms of their investments. So it ends up being a win-win. Michael (11:11.157)I think so. That’s what we see. Frazer Rice (11:13.316)So one thing that I’ve been sort of reading about and thinking about is the concept that the number of public companies is becoming less, well, it’s decreasing, and that many people are able to stay private for longer. Do you worry that your universe is going to get too small to provide sort of a canvas for your ideas here? 12:02 Market Trends and Future Outlook Michael (11:37.549)Let’s talk about three phases of that. We don’t, we actually see the data showing that there’s more and more opportunities within founder led. So let’s look at history and then let’s move to the future. So historically, probably about the time you and I joined the securities business, they would actually take the, to your point, they would take the founder, they would kick out this charismatic founder. They would put in some mid-level proctor or GE middle level manager to be the you know, the suit in the room to take the company public. And that was sort of in the late nineties and people figured out that wasn’t such a good idea. So if you actually look at the chart, there’s more and more founders staying and leading their public, their, their publicly traded companies. That’s number one. Number two. Yes. We have seen some companies stay private, obviously Stripe, SpaceX, but we are now seeing, for example, SpaceX coming to the public markets. Eli is talking about coming next year. so we, we haven’t seen it so far impact the pool with which we can fish in. And as I mentioned, that’s what we saw historically. Public Markets and the Future In the future, think, Frazer, I think we’re going to start to see a conversion of public and private markets, meaning these private mega cap companies have liquidity. And I think that you’ll see more and more ability to trade those stocks almost in public liquidity. So I think these two markets are converging. So I think that Not only do we have plenty of founders in the traditional public markets, I think that the liquidity and the big privates is going to converge to a public market style shortly anyway. Frazer Rice (13:13.232)You’re in a curious time as far as launching an ETF around this concept. I know a lot of people are wary of Mag-7 and ultra valuations and issues related to that. How do you respond to that concept that a lot of the growth has taken place in seven, maybe seven out of the hundred that you’ve chosen? Debunking the Mag-7 (to the Mag-3) Michael (13:33.356)Yeah, so that’s a misconception. We see Mike Saylor get on TV and wave his arms around it, but it’s not really true. First of all, what’s interesting, if you tear apart the Mag-7, it’s actually the Mag-3. The outperformance in the Mag-7 has come from Meta, Tesla, and NVIDIA. So it’s not just the Mag-7, it’s a founder led. And now you say, well, that’s a small sample set. Let’s look at a bigger sample set. So if you look at the NASDAQ 100, for example, It’s actually the 20 founder led companies have driven most of the outperformance over the last 25 years. And what I’m about to tell you about the S &P 500 probably won’t surprise you. It’s the 37 founder led companies that have driven most of the outperforming the S &P 500. So the outperformance is coming from founders, not from any specific part of the market. And one of the things that we think is great about this ETF is to avoid concentration. 14:50 Risk Management I know you’re really familiar with the concept of active share and that’s how different you are than the S &P 500. We have an 85 % active share to the S &P 500. So if you own the founders 100 ETF, you have much different exposure to the market than say the S &P 500. And so we think it helps reduce some of that concentration. We’ve done some things to make sure that we are diversified. First of all, we do own 100 stocks. Diversification So really good diversification across that. And then number two, while we run a market weight portfolio, we cap. No stock can be bigger than 7 % of the portfolio, so we don’t get out of balance at any point. So we think that we mitigate some of those concentration risks and we allow people to invest in innovation without being over concentrated to any one name, say the MAG-7, for example. So we think that we’re giving our investors really good exposure to innovation through the founders, but not exposing them to pre-existing market concentrations. And then finally remind everyone It’s not the MAG-7, it’s not the NASDAQ-100, it’s not the S &P-500, it’s the founders within each of these are what are driving the outsized performance in those analytical groups. Frazer Rice (15:36.218)So from a diversification standpoint, obviously not everything in one name, the 7 % cap you described, do you have sector concentration guidelines as well? Michael (15:45.749)We don’t have sector concentration guidelines, but if you look at the nature of the portfolio, we were fairly well diversified. We’re slightly overweight tech and financials versus say the S &P, but we own healthcare stocks, own consumer stocks, we own energy stocks. So we’re giving you a broad exposure to the market. Leverage Frazer Rice (16:05.924)Let’s talk about leverage for a second. I know a lot of people are trying to juice returns by piggybacking off of other people’s money on that front. Does that have a place in your ETF? Michael (16:17.004)So there’s no leverage in the ETF. We sort of believe in get rich the slow way. I like to tell people that it’s very hard to make money in the stock market over the short term, but it’s not particularly difficult over the very long term. think Mr. Munger and Mr. Buffett used to talk about this. the idea being, leverage can impact you in times that are not favorable. So we believe in just owning the stocks unlevered, let them compound over very long periods of time. And we think that by doing that, we and our shareholder, we think our shareholders can generate wealth over very long periods of time. Taxes Frazer Rice (16:54.98)So tax efficiency, the concept of holding period, does that play into your process at all? Michael (17:04.316)So remember within the ETF, as long as you’re managing your trading properly within the ETF, there’s no tax implications inside of it for your shareholders. Your shareholders only would be impacted at selling. So assuming they hold the stocks for over a year, any gains would be long-term capital gains treatment. Frazer Rice (17:27.024)And when you’re describing the investor profile that you’re looking to attract here, who is this for? Michael (17:35.916)Yeah, so the person that, you we really think it’s appropriate for you if you have a five year or more holding period and you want to have long-term capital appreciation. You know, if your goal is to be exposed to the best minds and public securities, that’s the founder led companies, and you want to compound your wealth over a very long period of time and have a high probability of outperforming the traditional broad market indexes, this ETF is designed for you. 17:59 Investor Profile and ETF Positioning Frazer Rice (18:04.705)And as you’re sort of outlining that profile and for those people who are trying to figure out where this fits in from an equity allocation perspective, you’re in charge in many ways of the spoke of a hub and spoke component of people are really sort of looking at indexes as the base of their equity portfolio. What are you looking for? What kind of benchmarks do you sort of measure yourself against? Michael (18:35.007)Yeah, so we think this is absolutely a core holding. So if you’re looking to build out you or your client’s portfolio, we think this should sit at the core. It is on the growth side, so it’s core growth. We think that it is a one-for-one replacement for, the NASDAQ 100. Or, for example, somebody holding the triple Qs. We think this is a better holding than the triple Qs. So we benchmark ourselves against them and against the S &P 500. Ee look at beating those two broad market indexes, generating better risk return for our investors. Frazer Rice (19:13.019)For those listeners that are out there and want to find out more, what’s the best way that they can either get a hold of you or maybe even better, do you have a ticker symbol ready that people can discover? FFF and Contact Information Michael (19:25.215)Yeah, absolutely. So the ticker is FFF. So that’s the FFF ETF that we’ll trade on. And investors can find that at their favorite brokerage firm, whether they’re Schwab customers, Interactive Brokers customers, Fidelity customers, trades under one ticker, just like a stock. Frazer Rice (19:44.365)And let’s take, we have a few minutes to go here, which is great. Your experience in terms of establishing the ETF, maybe a couple of some of the touch points when you went from vision to execution here, what was the process? Michael (20:00.106)Yeah, so ETF has a few basic processes that are regulated under the 1940 Securities Act. And so a lot of those rules are set up to protect the end investors. So for example, the securities live within a trust. So we set up our own trust. Some people use a mingled trust. We thought it was better for our end investors to have our own trust that we set up that has an independent trust board that oversees to make sure that we’re executing our strategies as we’ve outlined in the prospectus to make sure that we’re Doing the best we can for our investors. You’ve got to set that up There’s a few firms that do the plumbing for the for the ETFs would say US Bank is probably the largest player. So US Bank provides our our fund custody and fund administration and then there’s just a few other vendors in the space that sort of help with all the plumbing to make sure that the ETF runs smoothly. So it’s probably a six month process if you stay really focused to get all of that set up. 20:58 Navigating the ETF Launch Process Frazer Rice (21:03.313)You get that set up, how do you approach the Schwabs and the Fidelitys and the other platforms to make sure that people can access, buy, sell, whatever they want to do with your ETF? Michael (21:14.347)Yeah, that’s a great question. So the online brokerages typically put you on the platform as soon as you’re listed on a major US exchange. So you’ve got to get listed on NASDAQ, NYSE or CIBO. We chose CIBO. So again, on the traditional online brokers, you’re there day one. And then the big wire houses, JP Morgan, Goldman, Morgan Stanley, BAML, they typically have a few hurdles that you’ve got to get through, whether it’s daily trading liquidity assets under management. And over time, as you run the wickets through their process, you’re added to those platforms. Macro Issues? Frazer Rice (21:48.721)We live in a political age and a time when there’s just chaos everywhere, different types of rules in order to allocate capital. If you’re an investor trying to guess what’s happening politically, et cetera, that are difficult, you must be positive as far as the environment for founders to find success in this country and beyond. Is there anything that you’re looking for to make sure that those conditions hold? Michael (22:18.225)Yeah, we don’t really look at the macro or political backgrounds. think over very long periods of time, U.S. innovation outperforms. so we sort of we think that, again, one of the great things with investing in founders is they keep adapting as the background changes behind them. So we think over very long periods of time, the U.S. has great economic growth. And for those people that have worried about little blips along the way, we think the founders are the absolute best at mitigating those blips. Frazer Rice (22:48.334)I like to say you bet against America at your own peril and it sounds like from a founder perspective it’s still a great place for them to locate their businesses and grow them here. Michael (23:01.042)Absolutely. 23:50 Final Thoughts and Contact Information Frazer Rice (23:02.971)Just to reiterate, FFF is the ticker symbol for people to find it. any other contact points for people to find you if they’re interested in what you’re putting together. Michael (23:15.613)Yeah, so we have a great website at FounderETFs.com. can go check out there or anyone’s happy to email me, just michael at FounderETFs.com. Happy to chat with anyone who has interest about the portfolio, the strategy, or what we’re building. Frazer Rice (23:32.197)Well, great to have you back on, Mike. Thank you for putting up with my attempt at looking like Steve Jobs. It’s 25 degrees in New York here, and I am the stupid one who’s not in California or somewhere warm. appreciate you taking the time to be on and talking about your new product. Michael (23:48.011)Yeah, it was great to be on here. Really a huge fan of your podcast and just the level of guests that you’re able to interview and help educate your viewers. Frazer Rice (23:56.849)Mike, thanks for being on. Michael (23:59.061)Thanks a lot, Frazer. https://www.amazon.com/Wealth-Actually-Intelligent-Decision-Making-1-ebook/dp/B07FPQJJQT/ Previously with Mike Monaghan ETF EDUCATION ARTICLES ON ETF.COM

In this episode, Sasha Orloff speaks with Renato Villanueva, Founder and CEO of Parallel, about his journey from finance professional at Divvy to raising $2.4 million from Bain Capital and K5 Tokyo Black for an AI-powered FP&A platform that helps founders model financial scenarios and make confident growth decisions. Renato shares lessons on building products founders are passionate about rather than forced wedges, nurturing investor relationships, and how Parallel's approach has enabled customers to achieve significant growth—including one company that scaled from planning one sales hire to four, ultimately raising one of Utah's biggest Series A rounds. -- SPONSORS: Notion Boost your startup with Notion—the ultimate connected workspace trusted by thousands worldwide! From engineering specs to onboarding and fundraising, Notion keeps your team organized and efficient. For a limited time, get 6 months of Notion AI FREE to supercharge your workflow. Claim your offer now at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://notion.com/startups/puzzle⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Puzzle

In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD. Welcome to the Eyeluminaries podcast 00:10 Quick recap of episode 34 00:52 Intro of Julia A. Haller, MD, CEO 01:47 Tell us about changes you're seeing in leading a large academic center 02:16 How has residency changed in the last years? 06:23 Why are you involved in the Ophthalmology Foundation? 13:05 Intro of David F. Chang, MD 16:51 What do you think about the future of robotics in cataract surgery? 17:51 How do you continue to involve the patient in their care? 20:15 Dr. Chang discusses premium lenses 22:43 What's going on with EyeSustain and what are you excited about in the future? 27:00 Thank you! 35:30 Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital. David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

Are you building a business you could sell tomorrow, or are hidden mistakes quietly draining its value?In this episode, Bill joins a roundtable discussion with host Peter Levy, and other powerhouse leaders, including M&A dealmaker Alan Sharfstein, serial entrepreneur Bill Bartzak, strategic advisor Bill Barrett, and hands-on exit veteran John Peck. Together, they deconstruct the most urgent and overlooked truths about navigating the sale of your business, from killer red flags and ruthless buyer tactics to essential “owner's playbooks” for every stage.If you're tempted to DIY your deal, break this habit now. Tune in to protect your life's work, avoid devastating oversights, and hear real-world insights you won't find anywhere else. Listen now before the next buyer knocks. By then, you need to be ready.Timestamped Highlights[00:11] – The candid, emotional question that every seller must dare to ask[07:39] – How legendary entrepreneurs survived—and thrived—by switching lanes[09:47] – Why today's M&A market is exploding with both risk and opportunity[14:00] – The one “secret mentor” move that multiplies your business value overnight[21:27] – Shocking? How recurring revenue rewrites your exit story…or kills it[27:20] – The DIY disaster: True stories of owners who left millions on the table[34:07] – The “reverse diligence” test: Are you the buyer…or being bought?[41:12] – Fatal red flags, stealthy earnouts, and the non-negotiables in every deal[48:48] – When to bring your team into the trust circle—and how to handle it[54:28] – How top buyers quietly poach your secrets…and how to block themAbout the SpeakersPeter Levy is Senior Counsel at Mandelbaum Barrett, where he has called home for the past 11 years. As a trusted legal advisor and frequent moderator, Peter brings deep experience and pride in representing one of the finest law firms in the industry. With a longstanding reputation for strategic insight and an engaging, client-centered approach, Peter regularly facilitates panels and seminars for business owners, focusing on topics like exit strategies, business transitions, and personal growth within entrepreneurial careers. His perspective incorporates lessons from leading experts, blending practical business advice with inspiration from renowned thought leaders.

Welcome back to the Alt Goes Mainstream podcast.Today's interview is with a wealth management entrepreneur who created one of the most consequential wealth management technology companies that has helped to shape the industry into what it is today.Bill Crager is the Co-Founder of Envestnet, which he and his co-founder, the late Jud Bergman, grew into a public company. Bill was the CEO of Envestnet during the company's time as both a public company and following Bain Capital's acquisition to take the company private for $4.5B.Bill is now back at it again, joining iAltA Holdings as a Founding Partner to build a suite of businesses at the intersection of private markets and private wealth management infrastructure alongside former Ipreo CEO Scott Ganeles, former Ipreo Executive Bill Sherman, and former Blackstone CFO and WestCap Founder Laurence Tosi.Bill and I had a fascinating conversation about wealth management and private markets. We covered:The evolution of wealthtech.What advisors are looking for when it comes to technology.How technology can help advisors deliver a high-quality experience to clients.Why private markets are now playing such a big role in the business of wealth management.What is missing in private markets infrastructure.The role of AI in financial planning.Why Bill wanted to go back to building again.What is in store for iAltA.Thanks Bill for sharing your wisdom and expertise on private wealth and private markets.Show Notes00:00 Introduction to Early Technology00:12 Sponsorship Message from Ultimus02:09 Welcome to the Alt Goes Mainstream Podcast02:12 Introduction to Bill Crager04:19 Building Envestnet and Early Challenges05:06 Evolution of Wealth Management07:00 Adoption of Technology in Wealth Management08:39 Private Equity's Role in Wealth Management10:17 Horizontal vs. Vertical Solutions14:11 Challenges in Wealth Management Technology16:22 Data and Technology in Wealth Management22:41 Customization and Future of UMA24:30 Impact of Data on Private Markets26:30 Evergreen Funds and UMAs27:45 Fusion of Public and Private Markets28:07 Data Inputs for Financial Advice28:33 Building Financial Plans at Scale28:59 The Need for Holistic Financial Connectivity29:35 Challenges in Data Flow and Infrastructure30:29 The Role of AI in Financial Planning30:49 Balancing Machine Learning with Human Assurance31:35 AI's Impact on Financial Advice32:40 Future of Financial Planning with AI35:06 Trust in Technology vs. Human Advisors35:19 The Emotional Component of Financial Advice36:31 The Evolution of Wealth Management37:02 Tokenization in Wealth Management37:46 Adoption Challenges of Tokenization38:56 Leveraging Technology in Wealth Management39:27 The Future of Financial Advisors40:59 Advice for Young Financial Advisors42:10 The Role of Technology in Private Markets43:48 The Vision Behind iAltA44:46 Building Horizontal Solutions46:14 Creating Bridges in Financial Infrastructure51:00 The Future of Financial Advice IndustryEditing and post-production work for this episode was provided by The Podcast Consultant.A word from AGM podcast sponsor, Ultimus Fund SolutionsThis episode of Alt Goes Mainstream is brought to you by Ultimus Fund Solutions, a leading full-service fund administrator for asset managers in private and public markets. As private markets continue to move into the mainstream, the industry requires infrastructure solutions that help funds and investors keep pace. In an increasingly sophisticated financial marketplace, investment managers must navigate a growing array of challenges: elaborate fund structures, specialized strategies, evolving compliance requirements, a growing need for sophisticated reporting, and intensifying demands for transparency.To assist with these challenging opportunities, more and more fund sponsors and asset managers are turning to Ultimus, a leading service provider that blends high tech and high touch in unique and customized fund administration and middle office solutions for a diverse and growing universe of over 450 clients and 1,800 funds, representing $500 billion assets under administration, all handled by a team of over 1,000 professionals. Ultimus offers a wide range of capabilities across registered funds, private funds and public plans, as well as outsourced middle office services. Delivering operational excellence, Ultimus helps firms manage the ever-changing regulatory environment while meeting the needs of their institutional and retail investors. Ultimus provides comprehensive operational support and fund governance services to help managers successfully launch retail alternative products.Visit www.ultimusfundsolutions.com to learn more about Ultimus' technology enhanced services and solutions or contact Ultimus Executive Vice President of Business Development Gary Harris on email at gharris@ultimusfundsolutions.com.We thank Ultimus for their support of alts going mainstream.

This episode is sponsored by AlixPartners The Disruption Matters special podcast miniseries is back for its fourth season, and this year, leading industry experts will discuss how private markets can still deliver growth, despite the headwinds of a revolution in tech, geopolitics and global markets. All season long, we've argued that PE firms need to pursue growth even in times of uncertainty and volatility. But in our final episode of the year, we're clarifying that not all growth is created equal. The right kind of growth is cost-effective and sustainable. We explore the threats to sustainable growth, the need to shape growth strategies around exit routes, how buy-and-build strategies can go awry, and how to pause a growth strategy without stalling the company's progress. Guests include Jason McDannold, co-lead of the PE practice at AlixPartners; Halvor Horten, partner at Bain Capital; Jennifer Fox Bensimon, a managing director on the co-investment team of Partners Capital Investment Group; Emanuela Cisini, a partner, co-head of operational improvement and head of Mideast and Asia at Investindustrial; and Burak Kiral, a partner and managing director with AlixPartners.

Iggy Ioppe is Chief Investment Officer at Theo, a gateway connecting onchain capital to global markets via institutional-grade trading infrastructure. Previously, Iggy was Co-Head of Polygon Ventures and Managing Partner at Procul Capital, a fintech and Web3-focused venture firm. Earlier, he served as Group Head of Proprietary Investing at Credit Suisse and held investing roles at Sureview Capital, Vinik Asset Management, and Bain Capital. He holds a B.S. in Mathematics from McGill University and an MBA from Harvard Business School. In this conversation, we discuss:- The convergence of TradFi Crypto - High-speed traders are now the smartest folks on Wall Street  - Going beyond issuance - why tokenizing assets is not enough - Current trends in tokenized RWAs - The value of engaging tokenized assets in spot markets - The future of tokenized finance and the path to institutional adoption - Connecting to liquidity venues - HIP-3 exchange denominated in t-bills - Money-market funds - Tokenized gold with yield TheoX: @Theo_NetworkWebsite: theo.xyzLinkedIn: TheoIggy IoppeX: @iggyioppeLinkedIn: Iggy Ioppe---------------------------------------------------------------------------------This episode is brought to you by PrimeXBT.PrimeXBT offers a robust trading system for both beginners and professional traders that demand highly reliable market data and performance. Traders of all experience levels can easily design and customize layouts and widgets to best fit their trading style. PrimeXBT is always offering innovative products and professional trading conditions to all customers.  PrimeXBT is running an exclusive promotion for listeners of the podcast. After making your first deposit, 50% of that first deposit will be credited to your account as a bonus that can be used as additional collateral to open positions. Code: CRYPTONEWS50 This promotion is available for a month after activation. Click the link below: PrimeXBT x CRYPTONEWS50FollowApple PodcastsSpotifyAmazon MusicRSS FeedSee All

In this episode, we speak with David Katz, Managing Director at Charlesbank Capital Partners, a $24 billion AUM middle-market private equity firm that spun out of the Harvard Management Company in 1998. Drawing on its endowment heritage, Charlesbank takes a research-based approach to investing across its four target sectors: business & consumer services, healthcare, industrial, and technology. The firm partners with management teams to help businesses unlock value and accelerate growth. At Charlesbank, David oversees the firm's Business & Consumer Services sector team. Since formalizing the sector in 2019, Charlesbank has been among the most active and successful private equity investors in business services, including several notable realizations. Charlesbank views the services ecosystem as offering compelling and durable opportunities for continued private equity investment. David has been with Charlesbank for nearly 13 years, during which time he has also helped to advance the firm's investing system including its “fan of outcomes” underwriting approach. He is a member of the firm's Investment Committee, and previously worked at Bain Capital and McKinsey. I am your host, RJ Lumba. We hope you enjoy the show. If you like the episode click to follow.

Tiger Tyagarajan, Senior Advisor, BCG, Bain Capital and former CEO of Genpact, joins Replicant's Gadi Shamia to unpack why most enterprise AI fails. From broken org design to change-resistant cultures, Tiger reveals what's really holding transformation back, and how to fix it. In this episode:Why AI isn't a technology challenge, it's a leadership challengeThe real reason enterprise pilots stall (hint: it's not the model quality)Why being “AI-ready” means rewiring how decisions get madeWhat Tiger's seeing from CEOs who are doing it right (and wrong)The growing gap between incremental automation and true reinventionHow agentic AI will change enterprise operations forever

De twee bedrijven moesten nog even tot een overeenkomst komen, maar dat liet lang op zich wachten. Na maanden is er een akkoord: Microsoft houdt een belang van 27 procent in OpenAI. En ondertussen wordt het AI-bedrijf omgevormd naar een bedrijf dat ook winst mag maken. Dat maakt een beursgang mogelijk. En die kan al snel gebeuren. Hoe snel, dat hoor je in deze aflevering. Het is voorbij voor duizenden medewerkers van Meta, Amazon, UPS en ING. Het personeel moet naar huis, want voor het tweede jaar op rij denken al deze bedrijven dat ze hun banen kunnen vervangen door AI. We hebben het ook over NXP. Na anderhalf jaar durft de Nederlandse chipmaker weer te dromen over omzet- en winststijgingen. Met een omzetdaling van 'slechts' 2 procent zijn de kwartaalcijfers een meevaller. En wat zou je doen bij wéér slecht nieuws rond Philips? Dat bedrijf kreeg een brief op de mat van de Amerikaanse toezichthouder. Die waarschuwt: Philips houdt zich in drie fabrieken niet aan de procedures voor verantwoorde productie. Met de slaapapneu-affaire nog vers in het geheugen, drukken beleggers op de verkoopknop. Dan hoor je ook nog een beurs die hier normaal nóóit langskomt. De bestemming: Sydney, Australië. Daar staat het aandeel Domino's Pizza Enterprises genoteerd, het bedrijf achter een hele hoop Domino's filialen buiten de VS, ook in Nederland. Volgens Bloomberg zat er een overname aan te komen, een gerucht dat het aandeel 22 procent in de plus zette. Maar het was snel voorbij met de pret: het bedrijf sprak de geruchten snel tegen en toen donderde de koers weer in elkaar.See omnystudio.com/listener for privacy information.

De twee bedrijven moesten nog even tot een overeenkomst komen, maar dat liet lang op zich wachten. Na maanden is er een akkoord: Microsoft houdt een belang van 27 procent in OpenAI. En ondertussen wordt het AI-bedrijf omgevormd naar een bedrijf dat ook winst mag maken. Dat maakt een beursgang mogelijk. En die kan al snel gebeuren. Hoe snel, dat hoor je in deze aflevering. Het is voorbij voor duizenden medewerkers van Meta, Amazon, UPS en ING. Het personeel moet naar huis, want voor het tweede jaar op rij denken al deze bedrijven dat ze hun banen kunnen vervangen door AI. We hebben het ook over NXP. Na anderhalf jaar durft de Nederlandse chipmaker weer te dromen over omzet- en winststijgingen. Met een omzetdaling van 'slechts' 2 procent zijn de kwartaalcijfers een meevaller. En wat zou je doen bij wéér slecht nieuws rond Philips? Dat bedrijf kreeg een brief op de mat van de Amerikaanse toezichthouder. Die waarschuwt: Philips houdt zich in drie fabrieken niet aan de procedures voor verantwoorde productie. Met de slaapapneu-affaire nog vers in het geheugen, drukken beleggers op de verkoopknop. Dan hoor je ook nog een beurs die hier normaal nóóit langskomt. De bestemming: Sydney, Australië. Daar staat het aandeel Domino's Pizza Enterprises genoteerd, het bedrijf achter een hele hoop Domino's filialen buiten de VS, ook in Nederland. Volgens Bloomberg zat er een overname aan te komen, een gerucht dat het aandeel 22 procent in de plus zette. Maar het was snel voorbij met de pret: het bedrijf sprak de geruchten snel tegen en toen donderde de koers weer in elkaar.See omnystudio.com/listener for privacy information.

The ASX 200 fell 43 points to 9012 (0.5%) as resources were sold off heavily. Two blue chip casualties today too in CSL on a downgrade and delays to its demerger plans and WTC on ASIC raid on offices. Both falling heavily, CSL off 15.9% and WTC down 15.9% too. The All-Tech Index fell 1.1%. Gold miners under serious [pressure again today with NEM down 4.1% and NST falling 3.1% as bullion fell below US$4000. The Iron ore majors fared better with small losses, but rare earths dropped in a brutal sell down, LYC fell 13.9% and ILU down 5.2% with lithium stocks back on the chopping board as LTR dropped 12.8% and PLS fell 6.1%. Oil and gas stocks eased, WDS down 1.7% and uranium stocks fell, PDN down 4.4% and DYL off 2.5%. Banks though and other defensives were in demand. CBA up 1.4% and NAB rising 2.5% with the Big Bank Basket back up to $295.24 (+1.4%). Insurers gained too. QBE up1.5 % and SUN up 2.2%. Broker AUB got a NBIO from Swedish private equity, up 5.9% and SDF rose in sympathy. Industrials firmed, WES pushing ahead again, up 2.8% TLS up1.0 % and COL gaining 1.6%. In healthcare CSL weighed and tech stocks fell, WTC being responsible. In corporate news, media speculation on Bain Capital bidding for all or some of DMP saw the stock rocket before denial and profit taking killed it, still up 7.2%. FLT fell 0.9% as it sold its Cross Hotels business. On the economic front, Trump was in Japan meeting new PM Takaichi as the Fed kicks off its meeting tonight.Asian markets mixed ahead of framework trade deal, Japan down 0.8%, with HK and China mildly positive.Want to invest with Marcus Today? Our MT20 portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you. If you're looking for personal financial advice, our friends at Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.  Why not sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

The Information's Aaron Tilley and TMF Associates' Tim Farrar talk with TITV Host Akash Pasricha about a potential Apple and SpaceX satellite deal and Globalstar's rumored $10 billion sale. We also talk with Katie Roof's scoop that Adobe considered a $3 billion acquisition of AI video company Synthesia and Mike Shebat about how his company, Traba, is using AI to disrupt the light industrial staffing industry. The Information's Erin Woo joins us to detail Google's multimillion-dollar contract with Major League Hacking to push its Gemini AI model to young coders. Lastly, The Information's CEO and Editor-in-Chief Jessica Lessin speaks with Allison Braley, Partner at Bain Capital Ventures, to discuss modern communications strategies in the AI age.Articles discussed on this episode:https://www.theinformation.com/articles/apple-musks-spacex-finally-satellite-dealhttps://www.theinformation.com/articles/softbank-hunts-humanoid-robot-startupsTITV airs on YouTube, X and LinkedIn at 10AM PT / 1PM ET. Or check us out wherever you get your podcasts.Subscribe to: - The Information on YouTube: https://www.youtube.com/@theinformation4080/?sub_confirmation=1- The Information: https://www.theinformation.com/subscribe_hSign up for the AI Agenda newsletter: https://www.theinformation.com/features/ai-agenda

A trusted advisor. Years of history. Then the gut punch of a fraud that traces through Raj Markan, Merrill Lynch, Hilltop Securities, and a pitch invoking Bain Capital. In this follow up, Chalene Johnson lays out new receipts, what the FBI and SEC have already done, and how the scheme used off-channel communications to look legitimate. You will hear how victims were paid off, which red flags were missed, and the exact steps listeners can use to protect their money. If you have information or direct experience with Raj Markan, Merrill Lynch, Hilltop Securities, or Bain Capital, email TheChaleneShow@gmail.com

This week Matti Lievonen, EcoCeres joins Oscar on The SAF Podcast. Matti shares insights from his illustrious career from the transition from traditional refining at Neste to pioneering renewable fuel production in the rapidly expanding Asian SAF market.The conversation reveals the company's innovative approach to feedstock traceability, managing relationships with over 100,000 restaurants for used cooking oil collection, and their breakthrough "easy tracer" technology that tracks feedstock origins down to individual 30-kilogram contributions.This startup mentality, backed by significant investment from Bain Capital, has enabled rapid expansion with facilities in China and Malaysia collectively producing over 700,000 tons annually.The discussion explores critical industry challenges including feedstock security, the potential impact of China's anticipated SAF mandates in their upcoming five-year plan, and the complex dynamics between regional production and global supply chains. Lievonen addresses the tension between Europe's preference for local production versus Asia's capacity for large-scale, cost-effective manufacturing and export.Key topics include strategic partnerships with airlines like British Airways, the role of private equity investment from Bain Capital and Kerogen Capital, and the urgent need for policy harmonization across regions to accelerate SAF adoption. Lievonen also discusses consumer education challenges, cost reduction strategies through novel feedstock development, and the collaborative ecosystem approach needed to achieve aviation's 2050 decarbonization targets.Despite current cost barriers, Lievenen remains optimistic about SAF's future: "If you think about the time track, SAF has been now like five years old. If you think about fossil fuel, it's 100 years old. So we have time, and I'm sure we could find a way to make SAF very competitive but also well-used." Through collaboration across airlines, suppliers, and governments, the vision of truly sustainable aviation feels increasingly within reach.

A decade after Kraft and Heinz merged, the food giant is separating into two independent, publicly traded companies through a tax-free spinoff, Kroger faces a second patent infringement lawsuit, and in order to focus on its convenience-store business, Seven & i Holdings, parent of 7-Eleven convenience stores, has completed the sale of its York Holdings supermarket and specialty retail subsidiary to Bain Capital for more than $5.5 billion

In this episode of The Canadian Investor Podcast, we cover a packed week of market-moving news. We start with reports that Bain Capital may be taking Canada Goose private, with bids valuing the luxury parka maker well above its current market cap. Next, we break down Fed Chair Jerome Powell’s latest speech at Jackson Hole, where cooling growth, sticky inflation, and tariff-driven price shocks shaped the market’s outlook on rate cuts. We also look at Scotiabank’s surprising earnings beat, why their international arm is still a drag, and whether their promise of “pruning” is finally over. On the macro front, we discuss Trump’s efforts to reshape the Federal Reserve and the U.S. government’s growing trend of taking equity stakes in strategic companies like Intel and MP Materials. Finally, we wrap up with another strong quarter from Dollarama, which continues to post impressive growth while expanding globally. Tickers of stocks discussed: MP, INTC, DOL.TO, BNS.TO, LMT Check out our portfolio by going to Jointci.com Our Website Our New Youtube Channel! Canadian Investor Podcast Network Twitter: @cdn_investing Simon’s twitter: @Fiat_Iceberg Braden’s twitter: @BradoCapital Dan’s Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Web player - The Canadian Real Estate Investor Asset Allocation ETFs | BMO Global Asset Management Sign up for Fiscal.ai for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

For decades, private equity has been the darling of pension funds, university endowments, and sovereign wealth funds, promising high returns and low volatility. Now, President Donald Trump has made it possible for everyday investors to get in on the magic with his executive order, "Democratizing Access to Alternative Assets for 401(k) Investors.” The order relieves regulatory burdens that limit the access of defined contribution plans, like 401(k)s, to alternative assets such as private equity (but also cryptocurrency and real estate). The hope is to give American workers access to greater choice, diversification, and potential growth towards a comfortable retirement.But Trump's order comes just as longstanding questions about private equity's promise of high returns and low risk are coming to the fore. Has the distribution of returns slowed to a trickle? What does data actually say about private equity's performance, and where is the industry headed? There is also a long standing debate whether private equity is good for society, independent of financial returns.Is private equity actually a ponzi scheme that now threatens the retirements of millions of American workers? To make sense of it all, Luigi and Bethany are joined by Dan Rasmussen, an experienced investor and author who began his career in private equity but has emerged as one of the most prescient critics of the industry. Together, the three of them distill what the state of the industry means for the future welfare of investors, workers, and the American economy as a whole.Bonus: Check out ProMarket's recent series on the impact of private equity in the health care industry.

On paper, 360 One Wealth and Asset Management looks flawless: a ₹42,000 crore market cap, among India's largest pools of assets under management, and a co-founder CEO with a near-mythical reputation.But beneath that shine, the cracks are widening. Within a year, three of its most influential leaders—including co-CEO Anirudh Taparia—walked out, with over 100 employees following. Promoters and insiders are offloading stock, and even early backers like Bain Capital are quietly easing out.Officially, 360 One insists attrition is low and the fortress is intact. But industry insiders say otherwise—that the real impact of these exits is only beginning to play out.In this episode, we dig into the unraveling of an industry darling. Why are star rainmakers leaving? How deep does the unease among shareholders run? And what does it say about the future of wealth management in India as younger, more nimble rivals rise?Tune in. Do you work in IT? Take our surveyWant to join The Ken's team? Fill this form. 

In Episode #116 of Geeks of the Valley, we sat down with Jared Stein, Co-Founder at Monogram Capital, a leading private equity firm specializing in scaling high-growth, human-centric consumer brands.Jared walks through Monogram's investment philosophy and why the firm focuses on companies with deep consumer resonance. He shares insights from leading investments in Chewy.com, Olipop, Genexa, and Planet Fitness, detailing how emotional connection, strong brand equity, and operational excellence drive sustainable growth. The conversation explores the evolving role of private equity in consumer markets, including the increasing importance of wellness, trust, and personalization in shaping investment decisions.Drawing on his background at Bain Capital, Golden Gate Capital, HGGC, and Goldman Sachs, Jared also discusses lessons learned from scaling category leaders, the role of strategic partnerships, and how to balance value creation with authentic brand building.Whether you're an investor seeking differentiated strategies, a founder building a consumer brand, or a strategist tracking market shifts, this episode offers a deep dive into the future of human-centric private equity.

Heartflow, a California-based medtech company specializing in AI-driven cardiac diagnostics, plans to list on the Nasdaq under the ticker HTFL, offering 12.5 million shares at $15 to $17 each and targeting a valuation up to $1.3 billion. The company received FDA approval in 2022, expanded its market through Medicare and AMA regulatory changes, and has assessed over 400,000 patients as of March 2025. Heartflow reported $125.8 million in 2024 revenue, a 44% increase from the previous year, but posted a net loss of $96.4 million and expects continued losses. Major investors include Bain Capital, Panorama Point Partners, and Capricorn Investment Group. The IPO follows a previous canceled SPAC plan and recent public listings by other medtech firms.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

Hoy conversé con Diego Rodriguez, cofundador y CTO de Krea.ai, una plataforma que permite generar y editar imágenes y videos con IA en tiempo real. Con menos de 15 personas en el equipo, Krea ya es usada por Pixar, LEGO, Samsung y más de 20 millones de usuarios en todo el mundo.A la fecha, Krea ha levantado $83M de fondos como Bain Capital, a16z y Pebblebed.Diego y yo hablamos sobre:Por qué San Francisco es "la capital de lo rarosCómo un meme detonó su crecimiento de 0 a $20M en ARRPor qué el control y la personalización son el futuro de la IA creativaLa visión de crear modelos personalizados a sus usuariosNotas del episodio: https://startupeable.com/kreaPara más contenido síguenos en:YouTube  | Sitio Web En Startupeable, hacemos más con Notion, la plataforma todo en uno para organizar tu startup. Docs, tareas, bases de datos—todo en un solo lugar y ahora con IA para trabajar más rápido y mejor.Nos aliamos con Notion para regalarte 3 meses gratis del Plan Business + IA ilimitada, hasta 100 empleados

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane's Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit “Sam” Garg, MD and Jean-Pierre Hubschman, MD. Welcome to the Eyeluminaries podcast 00:05 Review of episode 33 00:49 Intro of Tibor Juhasz, PhD 01:35 Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27 How is ViaLase impacting glaucoma treatment? 06:55 How the treatment works 08:24 The importance of having a good team 11:02 Intro of Richard L. Lindstrom, MD 12:58 What is your perspective on what is happening today and what changes are you hoping for? 14:28 Integrated eye care delivery 17:00 Dentistry, a future model for eye care 17:50 Post-graduate medical education is changing 19:09 Was there a technology that you thought was a slam dunk and failed? 23:01 Any technology that you didn't expect to take off? 24:37 Intro of Sumit “Sam” Garg, MD 26:58 What do you see changing in ophthalmology residency programs around the country? 28:52 How do you instruct young physicians to be collaborative in care? 30:42 If you weren't a cornea specialist (or a model) what would you be? 32:10 Advice for young ophthalmologists today? 33:42 Share a Jim Mazzo story with us! 35:28 Intro of Jean-Pierre Hubschman, MD 37:07 Why did you, with a robotics company, decide to start in cataract surgery? 38:23 How do you become more efficient in robotic surgery? 41:00 How do we work on the economic side of this? 43:38 What's it like running a company vs being a retina surgeon? 44:46 Give us your feedback 48:16 Thanks for listening 48:30   Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS. Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News. Sumit “Sam” Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine. Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems.   We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

While the terms “uncertainty” and “volatility” get thrown around a lot, they certainly describe what's going on now in global markets, especially when it comes to private equity. In this episode of Redefiners, Clarke Murphy and Marla Oates talk with Bain Capital Co-Managing Partner John Connaughton to get his take on leading through change. As someone who has successfully managed through several periods of volatility during his more than 36-year career with Bain Capital, John takes us through how he's been able to look past current unpredictability with an eye towards the long term. He shares tips and key learnings on how to increase adaptability and agility across the firm, including AI adoption and transformation. He talks about recruiting and retaining top talent, and the top traits he looks for in leaders. Plus, he shares his thoughts on how universities can help redefine the skills needed for next generation leaders to excel in a rapidly changing world. We'll also hear from Chris Davis, a leadership advisor in our New York City office, who will discuss the critical leadership traits financial services CEOs need to master AI transformation.  Four things you'll learn from this episode: How to find and keep the best talent, including the top traits to look for in leadership How to build resilience and adaptability in teams to deal with uncertainty and change How technology and AI impacts investment strategy and growth How educational institutions need to redefine what skills will be needed in a rapidly changing world

Tariff turmoil, trade wars and real conflict in the Middle East – these are just some of the challenges private equity participants have had to navigate so far this year. Speaking to senior editor Adam Le, David Gross, co-managing partner at Bain Capital, said volatility and uncertainty is nothing new for investors. “I'd be the first to agree that it's a very disorienting time period,” Gross said. He points out, however, that volatility and uncertainty have characterised almost the past two decades. “Since the global financial crisis, we've seen heightened volatility in the investing world. If you just look at the VIX [volatility index] and other metrics, and the market windows that are open in the public market, you've seen heightened volatility." Gross, who has been with the firm for 25 years and is also managing partner of Asia, discusses what effective investors need in uncertain environments, the attraction of defence investing in Europe, the exit environment, and why the firm has no current plans to launch a secondaries investment business.

David Snider (https://www.linkedin.com/in/sniderdavida/) is the Founder & CEO of Harness Wealth, a platform that pairs modern tax software with a curated marketplace of elite CPAs, financial advisors, and trust-and-estate professionals. After stints at Bain Capital and Compass—where he helped raise $300 M and reach a $1.8 B valuation—David set out to fix the fragmented tax experience for equity owners and growing businesses.In this episode, Chris and David cover:Why most founders miss huge tax-planning opportunities—and how Harness closes the gapThe tech stack that lets CPAs spend less time chasing documents and more time advisingHarness's marketplace model: matching clients to vetted specialists without big-firm markupsLessons from Bain & Compass on scaling trust-based advisory businessesConnect with David & Harness Wealth:Website: https://www.harness.coLinkedIn: https://www.linkedin.com/in/sniderdavida/X: https://x.com/davidsniderhwMaximize your marketing, close more clients, and amplify your AUM by following us on:Instagram: https://instagram.com/ultrahighnetworthclientsTikTok: https://tiktok.com/ultrahighnetworthclientsYouTube: https://www.youtube.com/@uhnwcFacebook: https://www.facebook.com/UHNWCPodcastTwitter: https://twitter.com/uhnwcpodcastiTunes: https://podcasts.apple.com/au/podcast/ultra-high-net-worth-clients-with-chris-brodhead/id1569041400Spotify: https://open.spotify.com/show/4Guqegm2CVqkcEfMSLPEDrWebsite: https://uhnwc.comWork with us: https://famousfounder.com/faDISCLAIMER: This content is provided by Chris Brodhead for the general public and for general information purposes only. This content is not intended to be and should not be construed as an offer to buy or sell any securities or other investments. Investing involves risk, including the possible loss of principal. Investors should be prepared to bear potential losses and should carefully consider their own investment objectives, risk tolerance, financial situation, and needs before making any investment decision. Past performance is not indicative of future results. Always consult with a qualified financial, legal, or tax professional before implementing any strategy discussed herein.

This week on The Fin podcast: senior reporter Ayesha de Kretser and Chanticleer columnist Anthony Macdonald on Virgin’s return to the market, why it will struggle to stay in its lane and whether Australia can ever sustain more than two airlines.This podcast is sponsored by Aussie BroadbandFurther reading: Virgin prepares for IPO take-off in a test for Bain – and the marketFive years after collapsing into administration, the country’s second-largest airline will finally return to the ASX on Tuesday. There is a lot at stake.IPO market cracks open as Virgin, Greatland shares soar on debutFund managers rushed into the airline’s stock in a major win for Bain Capital, which has worked on turning around the business for five years.Virgin’s future is now in the hands of the markets godsThe problem with listing ceremonies is they look backwards, but investors look forward. The airline did what it must to relist, but now it’s over to the ASX.See omnystudio.com/listener for privacy information.

Being the biggest leader in your industry sector doesn't guarantee the future anymore. These days it can be quite the opposite, as we continue to witness big-dog leaders being dethroned by the next generation of agile tech-enabled competitors.On this episode of The Reboot Chronicles Show we have a sit down with Wayne Levings, a CEO, Chief Client Officer, and Executive Committee Member at Kantar, to learn from one of the biggest reboots of our decade.For Kantar, the struggle over the last decade has been real, as they have been through multiple reboots, adapting to the global power shifts in the market. The first reboot came with a mandate to breakup some of the pieces and spinout the company from the WPP Mothership through a partnership with Bain Capital. Now on their own, Kantar is a $3.5B marketing data and analytics powerhouse with 25,000 employees operating in 100 countries. With massive backing from Bain they have an opportunity to invest in next-gen areas, like AI and automation, and seize what's next. But it won't be easy to fight back and disrupt the disruptive disruptors.Watch or listen as we unpack this exciting reboot in progress, as they search for the perfect balance of AI and human-driven data—with a sneak peek into the future in this frothy hyper-competitive market being disrupted by AI.

Welcome back to the Alt Goes Mainstream podcast.Today's episode is with the CIO of an insurance company responsible for more than $300B in assets and a major focus on private markets.Lincoln Financial EVP and CIO Jayson Bronchetti and I sat down recently at Lincon Financial's headquarters in Radnor, Pennsylvania to discuss the increasing involvement of insurance companies in private markets.Jayson, who is a member of Lincoln Financial's Senior Management Committee and serves as the primary investment officer to Lincoln's Board of Directors on all investment-related matters, is responsible for more than $300B in assets across the general account portfolio and the separate account mutual fund complex. He's also chairman of the board of directors of the Lincoln Variable Insurance Product Trust family of over 100 mutual funds. He's also on the board of the Lincoln Financial Foundation.Fresh off recent partnerships with Bain Capital and Partners Group on private markets investment products and Bain Capital taking a stake in Lincoln's business, Jayson and I had a fascinating conversation about how insurance companies can approach private markets and how they can build unique and differentiated partnerships with asset managers.We discussed:The evolving role of insurance companies as LPs in private markets.Why asset and liability matching is a critical framework to allocating to private markets.How the general account of an insurance company creates interesting opportunities for strategic relationships and partnerships with alternative asset managers.The benefit of having a business that works with financial advisors and individuals.The importance of educating wholesalers about private markets – and why insurance wholesalers might have an advantage in educating advisors and clients about private markets products and strategies.Thanks Jayson for coming on the show to share your wisdom and expertise about private markets and insurance.Subscribe to Alt Goes Mainstream to receive the weekly newsletter every Sunday and all of AGM's podcasts.A word from AGM podcast sponsor, Ultimus Fund SolutionsThis episode of Alt Goes Mainstream is brought to you by Ultimus Fund Solutions, a leading full-service fund administrator for asset managers in private and public markets. As private markets continue to move into the mainstream, the industry requires infrastructure solutions that help funds and investors keep pace. In an increasingly sophisticated financial marketplace, investment managers must navigate a growing array of challenges: elaborate fund structures, specialized strategies, evolving compliance requirements, a growing need for sophisticated reporting, and intensifying demands for transparency.To assist with these challenging opportunities, more and more fund sponsors and asset managers are turning to Ultimus, a leading service provider that blends high tech and high touch in unique and customized fund administration and middle office solutions for a diverse and growing universe of over 450 clients and 1,800 funds, representing $500 billion assets under administration, all handled by a team of over 1,000 professionals. Ultimus offers a wide range of capabilities across registered funds, private funds and public plans, as well as outsourced middle office services. Delivering operational excellence, Ultimus helps firms manage the ever-changing regulatory environment while meeting the needs of their institutional and retail investors. Ultimus provides comprehensive operational support and fund governance services to help managers successfully launch retail alternative products.Visit www.ultimusfundsolutions.com to learn more about Ultimus' technology enhanced services and solutions or contact Ultimus Executive Vice President of Business Development Gary Harris on email at gharris@ultimusfundsolutions.com.We thank Ultimus for their support of alts going mainstream.Show Notes00:40 Introduction to Jayson Bronchetti02:20 Sponsor Message: Ultimus Fund Solutions03:37 Welcome to the Podcast04:03 Jayson's Background in Private Markets04:57 Evolution of Insurance Companies in Private Markets06:37 Symbiotic Relationship Between GPs and Insurers08:40 Understanding Liquidity and Illiquidity11:19 Diligencing Private Markets Managers13:25 Balancing Scale and Performance14:09 Boots on the Ground: Sourcing Edge14:42 Evolution of Alternative Asset Managers14:53 Lincoln's Unique Position in the Market19:32 Strategic Partnerships with Bain and Partners Group20:03 The Value of Distribution Relationships22:14 The Democratization of Alternative Investments22:49 The Intersection of Private Markets, Wealth, and Insurance23:10 Approaching Private Markets with the General Account24:18 Launching Strategies with Bain and Partners Group24:50 Incubating New Strategies for Retail Consumers25:16 Building a Customized Investment Strategy25:45 Designing Purposeful Investment Funds26:00 Ensuring Accessibility and Proper Wrappers26:08 Liquidity and Product Matching26:15 Seeding Strategies with the General Account26:58 One Lincoln Approach27:12 Finding Opportunities in the Seams27:46 Balancing General Account and Distribution Needs28:07 Product Innovation in the Wealth Channel28:53 Healthy Tension in Product Design31:51 Importance of Asset Liability Management33:05 Educating the Distribution Team34:47 Training Modules for Wholesalers36:28 Boots on the Ground: The Power of Relationships37:45 Simplifying Complex Products40:44 Democratizing Alternative Investments41:10 Straddling Institutional and Individual Mindsets41:35 Integrating Private Markets into Retirement Products43:13 Future of Private Markets in Retirement Portfolios43:57 Product Innovation and Technology45:15 Private Markets in Insurance Products47:16 Focus on Private Credit49:38 Risks in Private Credit50:29 Excitement for the Future of Private Markets51:01 Conclusion and Final Thoughts Disclosure from Lincoln Financial Registration statements for each of the evergreen funds have been filed with the Securities and Exchange Commission and are available from the EDGAR database on the SEC's website (www.sec.gov). The information in the registration statements is not complete and may be changed. The securities of neither fund may be sold until its registration statement is effective. An investor should consider the investment objectives, risks, charges and expenses of each fund carefully before investing. This and other information about each fund will be contained in the fund's final prospectus, which investors should read carefully when available from t...

Wanna learn how to comply with PFAS Removal targets with the lowest risk and without breaking the bank? Listen to this!More #water insights? Connect with me on Linkedin: https://www.linkedin.com/in/antoinewalter1/

In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02 Review of episode 32 00:55 Intro of Nicole Fram, MD 01:16 Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24 Meeting about complications from cataract surgery, what do you think is the next big phase on how we're going to handle complications with technology? 04:05 Psychology of managing patients/conveying care 05:42 What advice do you give to people who are starting their career? 06:50 Intro of Kerry Solomon, MD 09:30 What do we often get wrong with cataract surgery and what do we often get right? 10:25 How do you stay an entrepreneur and a leading physician? 11:55 What is Operation Sight? How did you create it? 14:19 Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30 Intro of Vance Thompson, MD 21:24 What's it like to be ASCRS president? 21:59 What is BRiCS and why is it important? 23:54 You've created a culture; can you talk about that culture you've created at your institute? 29:30 Tell us about your winery! 33:28 Intro of Steve Speares 36:45 ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00 As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57 Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19 Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29 Preview of episode 34 52:09 Give us your feedback 52:40 Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.

In this episode of Capital for Good we speak with Greg Shell, a seasoned investor, civic leader, and partner at Goldman Sachs Alternatives, where he leads the firm's inclusive growth strategy. Over the course of the conversation, we discuss how Shell's three decades and expertise in investing, and his commitments to creating opportunity and greater economic and social mobility, for many years pursued through board leadership and community and nonprofit engagement, have come together in impact investing, first at Bain Capital, and now at Goldman Sachs Alternatives.  Shell explains that he believes deeply in the power of capitalism — the power of the profit model to drive innovation, opportunities for ownership and wealth building, economic growth — and that the current system is failing to deliver broad based economic and social mobility. He notes that stagnant wages, growing income and wealth inequality, and deep and real economic insecurity, are all profound challenges, but ones that must and can be addressed.  “Our economy would be bigger and faster growing if more people could participate and contribute fully,” Shell says. This is also the thesis of the private equity strategy he leads at Goldman Sachs Alternatives that invests into affordable and high-quality health care, education and workforce development, and financial inclusion. In each vertical, Shell's team identifies companies that focus on remedying exclusion as social and economic challenge and market opportunity, where need drives demand, innovation expands access, and both lead to social impact and strong business fundamentals. We walk through two portfolio examples in education (online literacy intervention) and health care (autism services).  Despite the turbulence of the current environment, Shell is optimistic. “Human capital is the first, best and greatest asset we have,” he says. “Investing in human capital is always the right decision, and if we do it the right way” can deliver extraordinary returns, on every dimension. Thanks for Listening! Subscribe to Capital for Good on Apple, Amazon, Google, Spotify, or wherever you get your podcasts. Drop us a line at socialenterprise@gsb.columbia.edu.  Mentioned in this Episode Goldman Sachs Inclusive Growth 

“We want to bring health care to a place where claims are processed in real-time, like checking out on Amazon,” says Stephen Krupa, CEO of HealthEdge. Krupa joins Bloomberg Intelligence analyst Jonathan Palmer to unpack how HealthEdge’s core platform powers claims processing for more than 110 million people. He shares how legacy infrastructure still dominates (with 60% of health plans still relying on decades-old technology), why automation and gen AI will drive touchless transactions and how payer platforms must evolve to support member-centric care. Krupa also reflects on HealthEdge’s journey from startup to its transformation under Blackstone, and what the next chapter might look like with Bain Capital.See omnystudio.com/listener for privacy information.

When private-equity veteran Craig Boyce left nearly two decades at Bain Capital and neuroscientist Dr. Melanie Leitner stepped out of the lab, both carried a deeply personal mission: speed up the end of ALS. Together they helm the ALS Investment Fund, a for-profit venture vehicle that backs early-stage therapeutics aimed at turning the disease from terminal to chronically managed by filling the “capital void” between basic research and big-pharma buy-in​. In this conversation with Tim and Troy, Craig recounts losing his father to ALS and how that tragedy redirected his deal-making skills toward impact investing​, while Melanie shares the “seventh-grade brain report” that launched her career and why today's biomarker and platform-trial advances finally make true progress possible​. They break down: Why capital markets—not philanthropy alone—must fund $10-$50 M clinical trials ​ The business case that's luring big pharma back to neuro (“the decade of neurodegeneration”) ​ How a cystic-fibrosis-style royalty model could recycle billions into ALS research ​ The audacious goal to “put ourselves out of business” by making effective therapies commonplace ​ If you're curious how finance, science, and relentless human stories converge to accelerate cures, this episode delivers a front-row seat. SPONSORS: ElevenLabs: Thanks to ElevenLabs (https://elevenlabs.io) for supporting this episode and powering Tim's voice. ALS Investment Fund: Thanks to ALS Investment Fund (https://www.alsinvestmentfund.com) for supporting this episode. SOCIAL: Website: https://tgnlu.com   Twitter: https://twitter.com/nlutimgreen   Facebook: https://www.facebook.com/NLUpod  Instagram: https://www.instagram.com/nlupod/  AUDIO ONLY: Spotify: https://open.spotify.com/show/5fhcANt7CSnYvgBlgxpVVa  Apple Podcasts: https://podcasts.apple.com/us/podcast/nothing-left-unsaid/id1734094890   PERSONAL:  Tackle ALS: https://www.tackleals.com   Tim Green Books: https://authortimgreen.com Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.

What if the best idea for your business isn't coming from your C-suite, but from the intern who barely speaks in meetings? In this episode of The Liquid Lunch Project, hosts Matthew R. Meehan and Luigi “The Professor” Rosabianca sit down with Nick Jain, CEO of IdeaScale, to talk about shaking up the way businesses innovate. Nick drops no-BS insights on how small businesses can harness the power of crowdsourcing ideas, why financial fluency is non-negotiable, and how poker skills can make you a better entrepreneur.    Oh, and he's got a free tool for you small business owners that'll change how you brainstorm—stick around for that.   Episode Highlights: IdeaScale 101: Learn how this “social network for ideas” lets businesses crowdsource game-changing ideas from employees, customers, and beyond. Real-World Win: A global restaurant chain used IdeaScale to crowdsource their next big menu item—and it wasn't just a PR stunt. Big Company vs. Small Company Life: Nick spills the tea on why running a smaller company is like driving a speedboat—faster, riskier, and way more fun. Idea Meritocracy: Why the best ideas should win, not the loudest voice or the highest-paid suit.  Financial Fluency: Nick explains why every entrepreneur needs to master financial statements—or risk driving blind. Poker and Business: How calculated risks at the poker table mirror smart business moves. Free Tool Alert: IdeaScale is free for businesses under 100 people—zero strings attached.  Who is Nick? Nick Jain is the CEO of IdeaScale, a social network for ideas that helps businesses crowdsource innovation. A Harvard Business School grad and former Bain Capital hotshot, Nick's now running a midsize software company while juggling fatherhood, a computer science degree, and fixing electrical outlets at his rental properties.  Take Action: Want to stop chasing your tail and start innovating like a badass? Tune in to hear Nick Jain drop knowledge bombs that'll make you rethink how you run your business. Plus, snag a free tool that'll have your team's best ideas bubbling up faster than a cold beer on a hot day. Listen now—you'll thank us later. Favorite Quote: “If you can't read financial statements, you have no idea how your business is doing. It's like driving with covers on your windshield. You'd never do it.” Connect with Nick: X: https://x.com/NickMJain LinkedIn: https://www.linkedin.com/in/nickjain/ Website: https://ideascale.com   Like what you heard? Don't forget to subscribe, rate, and review!

In this episode of Goldman Sachs Exchanges: Great Investors, Alison Mass, chairman of investment banking in Goldman Sachs Global Banking & Markets, sits down with David Gross, co-managing partner of Bain Capital, to explore the evolving global landscape of private equity and alternative investments. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textOn today's episode, I'm joined by Sandeep Acharya — Founder and CEO of Octave, a company that's quietly but powerfully transforming how we experience mental health care in America. WATCH IT ON YOUTUBE.Under his leadership, Octave has partnered with major insurers to make high-quality, affordable therapy accessible across 23 states. It's been named a LinkedIn Top Startup and one of the best places to work in the country.Before founding Octave, Sandeep wore many hats: investor at Bain Capital and Insight, consultant at Bain & Company, and executive at One Medical, where he helped scale the company nationwide and saw firsthand how deeply unmet our mental health needs are.In this conversation, we go far beyond the bullet points — talking about his battle with cancer, the role of spirituality and music in his life, and what it really takes to build a company that's both mission-driven and sustainable. He shares unfiltered insights on leadership and navigating uncertainty.This one's for the builders, those fighting their own battles, and the believers.South Asian Trailblazers is an award-winning media platform, community, and agency dedicated to elevating leading South Asians. Join our community at SouthAsianTrailblazers.com. Subscribe to our newsletter to get new episodes and updates on our latest events in your inbox. Follow us @southasiantrailblazers on Instagram, LinkedIn, Facebook, Youtube, and all major podcast platforms, including Apple and Spotify.

Welcome to Omni Talk's Retail Daily Minute, sponsored by Mirakl. In today's Retail Daily Minute:Macy's Faces Mixed Earnings Amid Turnaround -- Macy's CEO Tony Spring continues to push forward with the First 50 store upgrades, which have shown stronger performance than the rest of the company. While Macy's exceeded earnings expectations, revenue missed estimates, signaling both progress and ongoing challenges in the retail sector. Google Integrates AI & AR for Smarter Shopping -- Google is enhancing its Shopping tab with Vision Match, a new AI-powered tool that allows users to describe a clothing item, and the system will generate shopping options that match the description. 3️⃣ 7-Eleven's Parent Company Reshapes Strategy -- Seven & i Holdings, the parent company of 7-Eleven, is undergoing a major transformation under its new CEO, Stephen Dacus, who is the first non-Japanese CEO in the company's history. The company has announced a $5.4 billion asset sale to Bain Capital, a move aimed at streamlining its operations and reinforcing its focus on the convenience store segment. Additionally, the company is planning an IPO for its North American operations, signaling an expansion push in the U.S. and Canada. The Retail Daily Minute has been rocketing up the Feedspot charts, so stay informed with Omni Talk's Retail Daily Minute, your source for the latest and most important retail insights. Be careful out there!

Top investor Melissa Bethell drops in to the studio in London to learn the names of countries such as USA, France and China in Chinese. ✨ BIG NEWS ✨ Our brand new Talk Chineasy App, is now live on the App Store! Free to download and perfect for building your speaking confidence from Day 1. portaly.cc/chineasy Visit our website for more info about the app.

En este episodio, analizamos los eventos más relevantes que están afectando los mercados y sectores clave: Wall Street reacciona a la Fed y aranceles de Trump: Los mercados caen ligeramente tras el récord del $SPX, mientras las minutas de la Fed reflejan cautela ante la inflación y políticas comerciales. Analizamos cómo estas preocupaciones están afectando la economía global. Asia en rojo por incertidumbre comercial: Japón y Hong Kong lideran las caídas tras la decisión de Trump de imponer aranceles del 25% a autos, chips y productos farmacéuticos. Exploramos cómo la política arancelaria de EE.UU. está impactando los mercados asiáticos. Microsoft avanza en computación cuántica: $MSFT presenta el Majorana 1, un chip basado en un nuevo estado de la materia, con el potencial de acelerar la computación cuántica en años, no décadas. Analizamos cómo esta tecnología podría transformar la industria y el impacto en acciones de cuántica como $QBTS, $QUBT y $IONQ. KKR adquiere Fuji Soft: La firma de inversión gana la batalla contra Bain Capital y compra el 57.92% de Fuji Soft por $4.4B. Evaluamos cómo esta adquisición busca potenciar la digitalización e IA en Japón. AstraZeneca expande su presencia en China: $AZN adquiere la filial china de FibroGen por $160M, obteniendo los derechos de roxadustat en el país. Discutimos cómo esta transacción impacta la estrategia global de ambas farmacéuticas. Acompáñanos para entender cómo estos eventos están moldeando los mercados, la tecnología y las estrategias corporativas. ¡Un episodio lleno de análisis estratégico!

Angelo Rufino, Partner and Head of Special Situations in North America and Head of Corporate Special Situations in Europe for Bain Capital, joins Bridget Walsh, EY Global Head of Private Equity. In this episode Angelo shares his insights on the differentiated opportunities for Special Situations investing. 17 mins. The views of third parties set out in this podcast are not necessarily the views of the global EY organization or its member firms. Moreover, they should be seen in the context of the time they were made.

John Rappaport is the Chief Investment Officer at Keyframe Capital, a special situations fund manager. They help management teams solve complex asset and corporate financing requirements. In finance speak, this is often referred to as structured capital—the process of separating a company's capital structure into layers, enabling each layer to be fit for an investor seeking that specific risk-return profile.As John shares, structured capital can often be a good fit for companies in the energy transition, as those in renewable energy and adjacent categories often have high upfront capital costs and a relatively low cost of ongoing production.John has spent much of his career in financial roles within the energy and transportation sectors. Prior to founding Keyframe in 2020, he joined Cyrus Capital Partners in 2008, and before that, he worked for Sankaty Advisors, a division of Bain Capital. He has lectured on structured capital and economics at Yale University and sits on the boards of many companies in the energy transition space, including Wonder Capital, Utility Data, and Sealed, among others.So, let's dive into the wonky but important world of structured capital.In this episode, we cover: [1:57] Overview of Keyframe Capital[2:52] The origin of Keyframe and a story about Terawatt Infrastructure[11:25] Understanding structured capital[17:01] Examples of structured capital: Infrastructure as a service[21:10] Keyframe's thesis-driven approach[25:56] The data center financing challenge[31:02] When and how founders should engage with structured capital providers[35:48] Keyframe's current focus areasEpisode recorded on Jan 21, 2025 (Published on Feb 6, 2025) Enjoyed this episode? Please leave us a review! Share feedback or suggest future topics and guests at info@mcj.vc.Connect with MCJ:Cody Simms on LinkedInVisit mcj.vcSubscribe to the MCJ Newsletter*Editing and post-production work for this episode was provided by The Podcast Consultant

Creativity through the lens of the CEO of IdeaScale"Taking a solution from another sphere of life and using it in a different space."Nick has lived an inspiring rags to riches story. Nick started his life by being raised by a single grandmother in a small city in India and graduated at the top of his class from Harvard Business School.Along the way, Nick has worked at some of the top investing firms in the world such as Bain Capital and Greenlight, and has led dramatic business transformations in 3 entirely different industries: trucking, men's shoes, and now B2B software.Nick is an expert at marketing, team management, and creating win-win-win outcomes for his 3 stakeholders (customers, employees, shareholders).Nick Jain is the CEO of IdeaScale, the leading innovation software company. IdeaScale is the core of many leading global organization's innovation efforts including NASA, Comcast, NASCAR, Doctors without Borders and many others.Nick graduated at the top of his class from Harvard Business School and holds a degree in mathematics from Dartmouth. He enjoys playing poker, running and travelling with his wife.https://ideascale.com/https://www.linkedin.com/in/nickjain/Send us a text

Ever wonder how tiger moms earned their stripes? In this Talk Chineasy Episode, learn how to say "tiger mom" and "tiger dad" in Chinese as ShaoLan and star investor Melissa Bethell discuss the cultural roots of Chinese "tiger parenting." ✨ BIG NEWS ✨ Our brand new Talk Chineasy App, is now live on the App Store! Free to download and perfect for building your speaking confidence from Day 1. portaly.cc/chineasy Visit our website for more info about the app.

Nick Jain is the CEO of IdeaScale, the world's largest innovation SaaS company. Raised in India by a single grandmother, he excelled academically, graduating at the top of his class at Harvard Business School and summa cum laude from Dartmouth with a triple major in math, physics, and economics. His career includes leading companies in trucking, men's fashion and software, as well as working at top investment firms like Bain Capital. An evangelist for AI adoption, Nick championed the use of large language models at IdeaScale well before the AI hype cycle began. He pushed for generative AI technologies to be adopted by sales, product designers, and even software engineers, well before such adoption became mainstream. Listen NOW to discover, 3 Ways To Future-Proof Yourself By Leveraging AI

ShaoLan and star investor Melissa Bethell reveal how to refer to a boss in Chinese. Find out why the literal translation of boss, "old plank" is not as insulting as the direct translation would have you believe! ✨ BIG NEWS ✨ Our brand new Talk Chineasy App, is now live on the App Store! Free to download and perfect for building your speaking confidence from Day 1. portaly.cc/chineasy Visit our website for more info about the app.

Today's show is our third in the Training Grounds mini-series, following Carnegie Corporation and Bain Capital to better understand how certain organizations have developed industry leaders. Wellington Management is one of the world's largest, privately held asset managers, managing over $1.3 trillion in assets with 875 investment professionals across 19 offices and a nearly 100 year history with an unusually low level of turnover along the way. Wellington has developed, recruited, and retained leading global investment talent across public equities, fixed income, and recently private markets as well. My guest to discuss this training ground is Jean Hynes, CEO of Wellington, who has spent more than thirty years at the firm starting as an administrative assistant. Our conversation covers Wellington's cultural values and boutique investment team model, including apprenticeship for junior talent, recruiting at the mid-level, and promotion all the way to partner. We then discuss Wellington's evolution from a U.S. equity value shop to a global, multi-asset, multi-strategy powerhouse, and Jean's evolution from a portfolio manager to CEO.   Take Capital Allocators Audience Engagement Survey Learn More Follow Ted on Twitter at @tseides or LinkedIn Subscribe to the mailing list Access Transcript with Premium Membership

Romney's Bain Capital helped dismantle left-wing talk network Air America. Will something similar happen to MSNBC? Republicans are gunning for Republicans. Will their be anything left beside subsidized right-wing propaganda?Plus- Thom reads from "How Wealth Rules the World: Saving Our Communities and Freedoms from the Dictatorship of Property" by Ben G. Price. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.